טוען...
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications
Advances in understanding the mechanisms of tumour-induced immunosuppression have led to the development of immune-checkpoint inhibitors in cancer patients, including those with renal cell carcinoma (RCC). The optimal combination between immunotherapy and targeted agents (as well as the possible fav...
שמור ב:
| הוצא לאור ב: | Drugs Context |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioExcel Publishing Ltd
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5992965/ https://ncbi.nlm.nih.gov/pubmed/29899754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212528 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|